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5-(3, 3-Dimethyl-l-triazeno) imidazole-4-carboxamide (DIC) is a well known antitumour agent undergoing clinical trial. It has the disadvantage of being very photosensitive. The related aryltriazenes, however, do not decompose in this fashion although they are acid labile, to an extent dependent on the ring substituents.
In the case of 1-aryl-3, 3-dialkyltriazenes, the ring substituents have no marked effect on the activity towards the TLX5 lymphoma. Replacement of both methyl groups by ethyl or isopropyl groups leads to inactivity, whereas if only one is replaced activity is retained. Microsomal metabolism experiments suggest that this is due to enzymic dealkylation to form the monoalkyl derivative.
Metabolism of I-aryl-3-methyl-3-alkyltriazenes gives the monomethyltriazene. Monomethyltriazenes are more acid labile and the activity of this metabolite is dependent on its half-life and hence the ring substituent. The dialkyltriazenes probably act as a slow release form of the monoalkyl metabolite, which is the active species.
UPTAKE OF SULPHONAMIDES BY ANIMAL TUMOURS AND THE ANTI
The distribution of several sulphonamides in various tissues of the mouse has been examined. When compared with their concentration in the liver, several of the sulphonamides showed preferential deposition in the PC6 plasma cell tumour. No correlation was found between the tumour/liver concentration ratio and pKa, Po or solubility in phosphate buffer. The corresponding 3, 3-dimethyltriazenes were synthesized and tested for their anti-tumour activity. Compared with a standard phenyl triazene, 2 of them had superior anti-tumour properties. The triazene prepared from sulphadiazine was labelled (14C) in the aryl moiety and (3H) in the methyl groups and its tissue distribution studied. No selective concentration in the tumour was found.
Studies of the metabolism of the triazenes suggest that the active metabolite is the monomethyl analogue which can decompose chemically into alkylating moieties. Para-hydroxy aniline mustard phosphate (AM-O-phos) was among the esters of p-hydroxy aniline mustard (AM-OH) synthesized with the aim that such conjugates would exhibit a specific cytotoxic effect, via the release of AM-OH, towards tumours containing high levels of the appropriate deconjugating enzymes (Bukhari, Everett and Ross, Biochem. Pharmac., 1971, 21, 963) . Subsequently AM-O-phos was showrh to be a substrate for selected phosphatases (Ball and Double, Biochem. Pharmac., 1974, 23, 3173) . In this work the cytotoxicity of AM-O-phos in HeLa cultures was studied in relation to the phosphatases of this cell line. The results are consistent with the view that the uptake of AM-OH is dependent on the activity of alkaline phosphatase, of the carcino placental type, located in the plasma membrane. No such dependence on acid phosphatase activity was observed. The cell culture model has also allowed the importance of extracellular phosphatase activity to be assessed. 
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